Evidence map›Paper›PMID 39338563›Full record

ReviewMicroorganisms2024

Coad Thomas Dow, Ellen S Pierce, Leonardo A Sechi

Abstract readReview
In one paragraph

Review in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Rapid and Simple Detection ofPathogens (Basel, Switzerland) · 2025
    Article
  7. A dataset on the phylogeny ofData in brief · 2025
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Coad Thomas DowMcPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0003-4301-6101
Ellen S PierceIndependent Researcher, Spokane Valley, WA 99216, USA.
Leonardo A SechiDepartment of Biomedical Science, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-0566-2049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human endogenous retroviruses (HERVs) are remnants of ancient retroviral infections that, over millions of years, became integrated into the human genome. While normally inactive, environmental stimuli such as infections have contributed to the transcriptional reactivation of HERV-promoting pathological conditions, including the development of autoimmunity, neurodegenerative disease and cancer. What infections trigger HERV activation?

Indexed as

Alzheimer’s disease (AD)amyotrophic lateral sclerosis (ALS)BNN27bromoepiandrosterone (BEA)glioblastomahuman endogenous retrovirus (HERV)multiple sclerosis (MS)Mycobacterium avium ss. paratuberculosis (MAP)Parkinson’s disease (PD)rheumatoid arthritis (RA)Temelimabtype 1 diabetes (T1D)

Identifiers

PMID39338563
PMCPMC11434025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.